Benefit Sharing in a Global Context: Working Towards Solutions for Implementation

Developing World Bioethics

Volumn 17, Issue 2, 2017, Pages 70-76

  Hurst, Daniel J ^a  

^a DUQUESNE UNIVERSITY   (United States)

Author keywords

benefit sharing; bioethics; clinical trials; developing world; research ethics

Indexed keywords

COOPERATION; ETHICS; HUMAN; INFORMATION DISSEMINATION; INTERNATIONAL COOPERATION; LEGISLATION AND JURISPRUDENCE; MEDICAL RESEARCH; SOCIAL JUSTICE;

BIOMEDICAL RESEARCH; COOPERATIVE BEHAVIOR; HUMANS; INFORMATION DISSEMINATION; INTERNATIONAL COOPERATION; SOCIAL JUSTICE;

EID: 84963751790     PISSN: 14718731     EISSN: 14718847     Source Type: Journal    
DOI: 10.1111/dewb.12118     Document Type: Article

References (27)

1. D. Schroeder. 2014. Sharing of Benefits. In Handbook of Global Bioethics. Henk ten Have and Bert Gordijn, ed. New York: Springer: 203-23.
2. D. Schroeder & J. C. Lucas. 2013. Benefit Sharing: From Biodiversity to Human Genetics—An Introduction. In Benefit Sharing: From Biodiversity to Human Genetics. New York: Springer: 1-7.
3. I. Mastroleo. Post-Trial Obligations in the Declaration of Helsinki 2013: Classification, Reconstruction and Interpretation. Dev World Bioeth 2015: 1-15.
4. D. Schroeder & E. Gefenas. Editorial. Revising the Declaration of Helsinki. BMJ May 8, 2013. Available at: http://www.bmj.com/content/346/bmj.f2837/rr/644552 [Accessed 5 March 2016].
5. R. S. Chennells. 2016. Equitable Access to Human Biological Resources in Developing Countries: Benefit Sharing Without Undue Inducement. New York: Springer.
6. D. P. Fidler. Negotiating Equitable Access to Influenza Vaccines: Global Health Diplomacy and the Controversies Surrounding Avian Influenza H5N1 and Pandemic Influenza H1N1. PLoS Med 2010. Available at: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1000247 [Accessed 5 March 2016].
7. R. Gatter. 2013. The New Global Framework for Pandemic Influenza Virus- and Vaccine-Sharing. In The Globalization of Health Care: Legal and Ethical Issues. I. G. Cohen, ed. New York: Oxford University Press: 277.
8. J. G. Ruggie. 2013. Just Business: Multinational Corporations and Human Rights. New York: W.W. Norton & Company: 3-6.
9. D. G. McNeil. 2001. Oxfam Joins Campaign to Cut Drug Prices for Poor Nations. The New York Times February 13. Available at: http://www.nytimes.com/2001/02/13/world/oxfam-joins-campaign-to-cut-drugprices-for-poor-nations.html [Accessed 5 March 2016].
10. J. R. Maxeiner. Some Realism about Legal Certainty in the Globalization of the Rule of Law. Houst J Int Law 2008; 31(1): 32.
11. M. W. Tvedt. 2014. Beyond Nagoya: Towards a Legally Functional System of Access and Benefit Sharing. In Global Governance of Genetic Resources: Access and Benefit Sharing After the Nagoya Protocol. S. Oberth€ur & G. K. Rosendal, eds. Oxon: Routledge: 158-59.
12. R. Wynberg, R. Chennells, & D. Schroeder. 2009. Conclusions and Recommendations: Towards Best Practice for Community Consent and Benefit Sharing. In Indigenous Peoples, Consent, and Benefit Sharing: Lessons from the San-Hoodia Case. R. Wynberg, D. Schroeder, & R. Chennells, eds. New York: Springer: 347-48.
13. D. Schroeder & J. C. Lucas. 2013. Towards Best Practice for Benefit Sharing Involving Access to Human Biological Resources: Conclusions and Recommendations. In Benefit Sharing: From Biodiversity to Human Genetics. D. Schroeder & J. C. Lucas, eds. New York: Springer: 228.
14. A.K. Page. Prior Agreements in International Clinical Trials: Ensuring the Benefits of Research to Developing Countries. Yale J Health Policy Law Ethics 2002; 3: 35–66.
15. L. Pessini & L. M. Martin. 2007. Brazilian Research Ethics: A North-South Dialogue Aiming to Build a New Culture of Respect. In Ethics in Biomedical Research: International Perspectives. M. H€ayry, T. Takala, & P. Herissone-Kelly, eds. Amsterdam: Rodopi: 50-53.
16. S. Colona & I. Schipper. 2015. Post-Trial Access to Treatment: Corporate Best Practices. Available at:http://www.somo.nl/publications-en/Publication_4169/at_download/fullfile [Accessed 5 March 2016].
17. R. Macklin. 2004. Double Standards in Medical Research in Developing Countries. Cambridge: University of Cambridge Press: 152.
18. L. London. Ethical Oversight of Public Health Research: Can Rules and IRBs Make a Difference in Developing Countries? Am J Public Health 2002; 92(7): 1079-84.
19. S. McIntosh, E. Sierra, A. Dozier, S. Diaz, Z. Quinones, A. Primack, G. Chadwick, & D. J. Ossip-Klein. “Ethical Review Issues in Collaborative Research between US and Low – Middle Income Country Partners: A Case Example. Bioethics 2008; 22(8): 414-22.
20. D. Schroeder, E. Gefenas, R. Chennells, V. Fournier, D. Feinholz, & G. Sirugo. 2013. Realizing Benefit Sharing: Is There a Role for Ethics Review? In Benefit Sharing: From Biodiversity to Human Genetics. Doris Schroeder & Julie Cook Lucas, eds. New York: Springer: 188-99.
21. S. Rennie. The FDA and Helsinki. Hastings Cent Rep 2009; 39(3): c3.
22. L. J. Burgess & D. Pretorius. FDA abandons the Declaration of Helsinki: The Effect on the Ethics of Clinical Trial Conduct in South Africa and Other Developing Countries. S Afr J Bioeth Law 2012; 5(2): 87-90.
23. E. J. Emanuel, D. Wendler, J. Killen, & C. Grady. What Makes Clinical Research in Developing Countries Ethical? The Benchmarks of Ethical Research. J Infect Dis 2004; 189(5): 930-37.
24. Fair Benefits for Research in Developing Countries: Participants in the 2001 Conference on Ethical Aspects of Research in Developing Countries. Science 2002; 298 : 2133–4.
25. F. Barchi, M. K. Singleton, & J. F. Merz. Fostering IRB Collaboration for Review of International Research. Am J Bioeth 2014; 14(5): 3-8.
26. P. A. Marshall. 2007. Ethical Challenges in Study Design and Informed Consent For Health Research in Resource-Poor Settings. France: World Health Organization: 13-14.
27. A. Hyder, W. Zafar, J. Ali, R. Ssekubugu, P. Ndebele, & N. Kass. Evaluating Institutional Capacity for Research Ethics in Africa: A Case Study from Botswana. BMC Med Ethics 2013; 14(31): 1-2.